Skip to main content

1,2-Dihydroisoquinoline Derivatives as New Carrier for Brain Specific Delivery.

Research Authors
Sahar M. Mohamoud, Mahmoud M. Sheha, Tarek Aboul-Fadl and Hassan H. Farag.
Research Journal
Assiut University Third Pharmaceutical Sciences Conference, Assiut-Egypt, March 5-6 (2002)
Research Rank
3
Research Year
2002

1,2-Dihydroisoquinoline Derivatives as New Carrier for Brain Specific Delivery.

Research Authors
Sahar M. Mohamoud, Mahmoud M. Sheha, Tarek Aboul-Fadl and Hassan H. Farag.
Research Journal
Assiut University Third Pharmaceutical Sciences Conference, Assiut-Egypt, March 5-6 (2002)
Research Member
Research Rank
3
Research Year
2002

1,2-Dihydroisoquinoline Derivatives as New Carrier for Brain Specific Delivery.

Research Authors
Sahar M. Mohamoud, Mahmoud M. Sheha, Tarek Aboul-Fadl and Hassan H. Farag.
Research Journal
Assiut University Third Pharmaceutical Sciences Conference, Assiut-Egypt, March 5-6 (2002)
Research Member
Research Rank
3
Research Year
2002

2Unusual “Senseless” 2’-5’ Oligoribonucleotide with a Potent Anti-HIV Activity.

Research Authors
Tarek Aboul-Fadl, Vijai Agrawal, Robert W. Buckheit Jr and Arthur D. Broom.
Research Journal
The 1st International Congress of Pharmaceutical and Drug Industries Division, National Research Center, Cairo-Egypt, March 24-26(2003).
Research Rank
3
Research Year
2003

Synthesis and Antitubercular Activity of some Schiff Bases Derived from Mannich Bases of Isatin and Isonicotinic Acid Hydrazide (INH).

Research Authors
Mostafa Hussein, Tarek Aboul-Fadl and Asmaa Abdel-Nasser.
Research Journal
Polish-Austrian-German-Hungarian-Italian Joint Meeting on Medicinal Chemistry, KrakÓw, Poland 15-18 October 2003.
Research Rank
3
Research Year
2003

Synthesis and Antitubercular Activity of some Schiff Bases Derived from Mannich Bases of Isatin and Isonicotinic Acid Hydrazide (INH).

Research Authors
Mostafa Hussein, Tarek Aboul-Fadl and Asmaa Abdel-Nasser.
Research Journal
Polish-Austrian-German-Hungarian-Italian Joint Meeting on Medicinal Chemistry, KrakÓw, Poland 15-18 October 2003.
Research Rank
3
Research Year
2003

Phase II Drug Metabolizing Enzyme mRNA Changes by Novel Selenazolidine Prodrugs of Selenocysteine in Mice.

Research Authors
Wael M. El-Sayed, Tarek Aboul-Fadl, Ronald B. McEwen, Tenley Schofield, John G. Lamb, Jeanette C. Roberts and Michael R. Franklin.
Research Journal
The 22nd Annual Meeting of the Mountain West Society of Toxicology (MWSOT), Park City – Utah, USA. September 9-10, 2004.
Research Rank
3
Research Year
2004

Hepatic effects of novel selenazolidine prodrugs of selenocysteine developed as potential cancer chemopreventive agents.

Research Authors
Tarek Aboul-Fadl, Wael M. El-Sayed, Tenley Schofield, Jonathan Constance, John G. Lamb, Jeanette C. Roberts, and Michael R. Franklin.
Research Journal
229th ACS National Meeting, San Diego, California, USA, March 13-17, 2005.
Research Publisher
ACS
Research Rank
3
Research Year
2005

Uptake of L-Selenaproline by the L-Cystine Transport System in Escherichia coli.

Research Authors
C. E. Deutch, M. E. Arballo, L. N. Cooks, J. M. Gomes, T. M. Williams, T. Aboul-Fadl, and J. C. Roberts.
Research Journal
105th General Meeting of the American Society for Microbiology, Atlanta, Georgia, USA, June 5-9, 2005.
Research Rank
3
Research Year
2005
Subscribe to